Clinical trial
Xe129 Magnetic Resonance Imaging of the Lung: A New Technology to Assess Treatment for COPD
NCT02826343 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Xe129 Magnetic Resonance Imaging of the Lung: A New Technology to Assess Treatment for COPD
- Lead sponsor
- University of Virginia
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 1, 2016
- Completion date
- June 15, 2018
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.